We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hormone Test May Reduce Rate of Teens Misdiagnosed with PCOS

By LabMedica International staff writers
Posted on 19 Sep 2016
Measuring blood levels of the recently discovered hormone irisin may improve accurate diagnosis rates of teenagers with polycystic ovary syndrome (PCOS) and so reduce the number of unnecessary treatments prescribed to healthy girls at an especially critical stage in their lives.

Doctors are cautious when diagnosing PCOS in teenagers because the symptoms can be confused with normal pubertal changes. More...
Women with PCOS are more likely to suffer from irregular periods, have excessive levels of male hormones, and may have difficulty in conceiving due to irregularities in the ovaries. The cause of PCOS is unknown and there is currently no cure. Studies have associated high levels of irisin, which is released from muscles and regulates energy metabolism, with PCOS in adults.

In the new study, researchers from Aghia Sophia Children's Hospital (Athens, Greece) compared the hormones of 23 teenagers with PCOS with 17 healthy teenagers of the same age and BMI. They found that the teens with PCOS had significantly higher irisin levels compared to the healthy control group, and that this was associated with higher levels of the male sex hormone testosterone, a key marker of PCOS.

The findings suggest that irisin could be a marker for PCOS, enabling the condition to be diagnosed more easily. "Teenagers who get an early diagnosis of PCOS can sooner start to deal with the physical and psychological symptoms caused by this lifelong condition," said lead researcher Dr. Flora Bacopoulou, "Whether it's through counseling or medication, girls can manage their symptoms and decrease the risk of further complications such as fertility problems, hirsutism (excessive hair growth), and type-2 diabetes."

The group will next focus on confirming their results and investigate the biological role of irisin in PCOS. "If high irisin levels in teenagers with PCOS is established, this could lead to the development of treatments for PCOS. Lifestyle changes and different exercise-related signals that regulate the secretion of irisin could provide a potential option for the management of PCOS. The potential of irisin as a meaningful drug target in PCOS is very promising," said Dr. Bacopoulou.

The study was presented September 11, 2016, at the 55th Annual European Society for Paediatric Endocrinology Meeting (Paris, France, September 10-12).

Related Links:
Aghia Sophia Children's Hospital


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.